Current Neuro-Oncology

Volume 25 Number 8
30 April 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 8, 30 April

Amodeo V, Davies T, Martinez-Segura A, Clements MP, Ragdale HS, Bailey A, Dos Santos MS, MacRae JI, Mokochinski J, Kramer H, Garcia-Diaz C, Gould AP, Marguerat S, Parrinello S.
Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cells.
Dev Cell. 2023 Apr 17:S1534-5807(23)00148-X. doi: 10.1016/j.devcel.2023.03.021. PMID: 37084728. Laboratory investigation. ˍ

Pieri V, Curti DG, Paterra R, Azzimonti M, Sferruzza G, Berzero G, Cardamone R, Anzalone N, Agosta F, Caso F, Magnani G, Finocchiaro G, Filippi M.
CSF-based liquid biopsy pointing to a diagnosis of diffuse glioma in a patient with supposed neurodegenerative disorder.
Neurol Sci. 2023 Apr 17. doi: 10.1007/s10072-023-06806-9. PMID: 37067723. Case report˰ ˍ

Saluja S, Razzaq B, Servider JA, Seidman R, Mushlin H.
Diffuse midline glioma, H3K27-altered, of the conus medullaris presenting as acute urinary retention: illustrative case.
J Neurosurg Case Lessons. 2023 Apr 17;5(16):CASE22529. doi: 10.3171/CASE22529. PMID: 37070683. Case report. ˍ

Cheng C, Wang D, Yu M, Zhai Y, Pan C, Liang B, Zhang J, Wang C, Yin Y, Li L, Wu F, Shi Z, Fan X, Liu X, Wang Z, Zhao Z, Li G, Jiang T, Zhang W; Chinese Glioma Genome Atlas (CGGA) Network.
Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.
Neurosurgery. 2023 Apr 18. doi: 10.1227/neu.0000000000002495. PMID: 37070826. Observational study. ˍ

Liu X, Zhang X, Ma T, Li M, Zhang L, Li S, Zeng M, Kass IS, Peng Y.
Risk factors for postoperative thrombosis-related complications in patients undergoing malignant brain tumor resection: a retrospective cohort study.
Front Neurol. 2023 Apr 18;14:1108596∟. doi: 10.3389/fneur.2023.1108596
. PMID: 37144008. Observational study. ˍ

Datta D, Dasgupta A, Chatterjee A, Sahu A, Bhattacharya K, Meena L, Joshi K, Puranik A, Dev I, Moiyadi A, Shetty P, Singh V, Patil V, Menon N, Sridhar E, Sahay A, Gupta T.
Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma.
J Pers Med. 2023 Apr 19;13(4):685. doi: 10.3390/jpm13040685. PMID: 37109071. Observational study. ˍ

Gubbiotti MA, Dhillon KS, Harris J, Kothari S, Ware JB, Desai A, Shabason J, Miettinen M, Quezado M, Aldape K, Judy K, Wang ZX, Curtis MT, Nasrallah MP.
An unusual case of metastatic diffuse midline glioma in an adult.
J Neuropathol Exp Neurol. 2023 Apr 19:nlad032. doi: 10.1093/jnen/nlad032. PMID: 37075315. Case report. ˍ

Han RH, Johanns TM, Roberts KF, Tao Y, Luo J, Ye Z, Sun P, Blum J, Lin TH, Song SK, Kim AH.
Diffusion basis spectrum imaging as an adjunct to conventional MRI leads to earlier diagnosis of high-grade glioma tumor progression versus treatment effect.
Neurooncol Adv. 2023 Apr 19;5(1):vdad050. doi: 10.1093/noajnl/vdad050. PMID: 37215950. Observational study. ˍ

Isfaoun Z, Laasri K, Jidal M, Cherradi N, Melhaoui A, Chat L, Haddad SE, Kababri ME, Khorassani ME, Kili A, Ansari NE, Hessissen L.
A rare presentation of a spinal diffuse midline glioma in a child: a case report.
Pan Afr Med J. 2023 Apr 19;44:183. doi: 10.11604/pamj.2023.44.183.39885. PMID: 37484594. Case report. ˍ

Agrawal K, Verma KK, Hussain N, Sarangi S.
A rare case of cerebellar anaplastic pleomorphic xanthoastrocytoma.
J Cancer Res Ther. 2023 Apr 20;19(5):1465-1467. doi: 10.4103/jcrt.jcrt_1115_21. PMID: 37787332. Case report. ˍ

Dao Trong P, Jungwirth G, Unterberg A, Herold-Mende C, Warta R.
The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells.
Cells. 2023 Apr 20;12(8):1200
. doi: 10.3390/cells12081200. PMID: 37190109. Laboratory investigation. ˍ


Amodeo V, Davies T, Martinez-Segura A, Clements MP, Ragdale HS, Bailey A, Dos Santos MS, MacRae JI, Mokochinski J, Kramer H, Garcia-Diaz C, Gould AP, Marguerat S, Parrinello S.
Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cells.
Dev Cell. 2023 Apr 20:S1534-5807(23)00148-X. doi: 10.1016/j.devcel.2023.03.021. PMID: 37084728. Laboratory investigation. ˍ

Cole KA, Ijaz H, Surrey LF, Santi M, Liu X, Minard CG, Maris JM, Voss S, Reid JM, Fox E, Weigel BJ.
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.
Cancer. 2023 Apr 20. doi: 10.1002/cncr.34786. PMID: 37081608. Interventional study. ˍ

Eppy Buchori Aristiady K, Ellya.
A rare case of primary spinal cord oligodendroglioma.
Radiol Case Rep. 2023 Apr 20;18(6):2303-2306. doi: 10.1016/j.radcr.2023.03.050. PMID: 37153481. Case report. ˍ

Geoerger B, Marshall LV, Nysom K, Makin G, Bouffet E, Defachelles AS, Amoroso L, Aerts I, Leblond P, Barahona P, Van-Vlerken K, Fu E, Solca F, Lorence RM, Ziegler DS.
Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial.
Eur J Cancer. 2023 Apr 20;188:8-19. doi: 10.1016/j.ejca.2023.04.007. PMID: 37178647. Interventional study. ˍ

Schmidt AQ, von Euw S, Roy JM, Skandalakis GP, Kazim SF, Schmidt MH, Bowers CA.
Frailty predicts hospital acquired infections after brain tumor resection: Analysis of 27,947 patients' data from a prospective multicenter surgical registry.
Clin Neurol Neurosurg. 2023 Apr 20;229:107724. doi: 10.1016/j.clineuro.2023.107724. PMID: 37119655. Observational study˰ ˍ

Gupta S, Nawabi NL, Emani S, Medeiros L, Bernstock JD, Duvall J, Ng P, Smith TR, Wen PY, Reardon DA, Arnaout O.
An expanded role for surgery in grade 3 1p/19q co-deleted oligodendroglioma.
Neurooncol Adv. 2023 Apr 21;5(1):vdad046
. doi: 10.1093/noajnl/vdad046. PMID: 37215951. Observational study. ˍ

Zhu P, Li SY, Ding J, Fei Z, Sun SN, Zheng ZH, Wei D, Jiang J, Miao JL, Li SZ, Luo X, Zhang K, Wang B, Zhang K, Pu S, Wang QT, Zhang XY, Wen GL, Liu JO, August JT, Bian H, Chen ZN, He YW.
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C.
J Pharm Anal. 2023 Apr 21;13(6):616-624. doi: 10.1016/j.jpha.2023.04.012. PMID: 37440907. Case report. ˍ

Darcourt J, Chardin D, Bourg V, Gal J, Schiappa R, Blonski M, Koulibaly PM, Almairac F, Mondot L, Le Jeune F, Collombier L, Kas A, Taillandier L, Verger A.
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.
Eur J Nucl Med Mol Imaging. 2023 Apr 22. doi: 10.1007/s00259-023-06225-0. PMID: 37086272. Interventional study˰ ˍ

Chi H, Wang Q, Han Z, Li X, Zhang K, Qi M, Feng Z, Jia D, Han B, Ni S, Xue H, Li G.
Intraoperative rapid molecular diagnosis validates MRI-based glioma boundary evaluation: A case report.
CNS Neurosci Ther. 2023 Apr 23. doi: 10.1111/cns.14233. PMID: 37088946. Letter to the editor, Case report. ˍ

Alalami H, Bannykh S, Fan X, Hu J.
Very long-term survival of an older glioblastoma patient after treatment with cilengitide: a case report.
CNS Oncol. 2023 Apr 24:CNS96. doi: 10.2217/cns-2022-0017. PMID: 37092563. Case report. ˍ

Kelly W, Diaz Duque AE, Michalek J, Konkel B, Caflisch L, Chen Y, Pathuri SC, Madhusudanannair Kunnuparampil V, Floyd J, Brenner A.
Phase II Investigation of TVB-2640 (denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma.
Clin Cancer Res. 2023 Apr 24:CCR-22-2807. doi: 10.1158/1078-0432.CCR-22-2807. PMID: 37093199. Interventional study. ˍ

Korshunov A, Okonechnikov K, Schrimpf D, Tonn S, Mynarek M, Koster J, Sievers P, Milde T, Sahm F, Jones DTW, von Deimling A, Pfister SM, Kool M.
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Acta Neuropathol. 2023 Apr 24. doi: 10.1007/s00401-023-02575-z. PMID: 37093271. Laboratory investigation˰ ˍ

Graen P, Christiansen H, Polemikos M, Heetfeld C, Feuerhake F, Wiese B, Merten R.
Moderately Hypofractionated Radio(chemo)therapy With Simultaneous Integrated Boost for Recurrent, Previously Irradiated, High-grade Glioma.
Anticancer Res. 2023 Apr 25;43(5):2155-2160. doi: 10.21873/anticanres.16377. PMID: 37097672. Observational study˰ ˍ

Irikura T, Fukuoka K, Nakazawa A, Ichimura K, Kurihara J, Koh K.
Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation.
Childs Nerv Syst. 2023 Apr 25
. doi: 10.1007/s00381-023-05971-8. PMID: 37185696. Case report˰ ˍ

Wang X, Li X, Wu Y, Hong J, Chai D, Zhang M.
Risk of cardiac-related death in astrocytoma patients treated with chemotherapy: A competing risk analysis using the SEER database.
Front Cardiovasc Med. 2023 Apr 25;10:996354. doi: 10.3389/fcvm.2023.996354. PMID: 37180801. Observational study. ˍ


Zhang S, Guo S, Yu M, Wang Y, Tao L, Zhang X.
Analgesics can affect the sensitivity of temozolomide to glioma chemotherapy through gap junction.
Med Oncol. 2023 Apr 26;40(6):162. doi: 10.1007/s12032-023-01998-8. PMID: 37100898. Laboratory investigation˰ ˍ

Graef J, Bluemel S, Brenner W, Amthauer H, Truckenmueller P, Kaul D, Vajkoczy P, Onken JS, Furth C.
[177Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement.
J Nucl Med. 2023 Apr 27:jnumed.122.264850. doi: 10.2967/jnumed.122.264850. PMID: 37116918. Observational study˰ ˍ

Ranjan T, Sengupta S, Glantz MJ, Green RM, Yu A, Aregawi D, Chaudhary R, Chen R, Zuccarello M, Lu-Emerson C, Moulding HD, Belman N, Glass J, Mammoser A, Anderson M, Valluri J, Marko N, Schroeder J, Jubelirer S, Chow F, Claudio PP, Alberico AM, Lirette ST, Denning KL, Howard CM.
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.
Cell Rep Med. 2023 Apr 27:101025
. doi: 10.1016/j.xcrm.2023.101025. PMID: 37137304. Interventional study. ˍ

Yamada CAF, Soldatelli MD, do Amaral LLF, Campos CMS, de Moraes PL, Chaddad-Neto FEA, Lancellotti CLP.
Case Report: Evolutionary Clinical-Radiological Features of a Diffuse Hemispheric Glioma, H3 G34 Mutant with Over 5 Years of Survival.
Case Rep Oncol. 2023 Apr 27;16(1):279-286
. doi: 10.1159/000530181. PMID: 37123609. Case report. ˍ

Alafandi A, van Garderen KA, Klein S, van der Voort SR, Rizopoulos D, Nabors L, Stupp R, Weller M, Gorlia T, Tonn JC, Smits M.
Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status.
Eur J Cancer. 2023 Apr 28;188:122-130
. doi: 10.1016/j.ejca.2023.04.021. PMID: 37235895. Observational study. ˍ

Cheng L, Zhang F, Zhao X, Wang L, Duan W, Guan J, Wang K, Liu Z, Wang X, Wang Z, Wu H, Chen Z, Teng L, Li Y, Xiao F, Fan T, Jian F.
Mutational landscape of primary spinal cord astrocytoma.
J Pathol. 2023 Apr 28. doi: 10.1002/path.6084. PMID: 37114614. Laboratory investigation˰ ˍ

Choi DJ, Armstrong G, Lozzi B, Vijayaraghavan P, Plon SE, Wong TC, Boerwinkle E, Muzny DM, Chen HC, Gibbs RA, Ostrom QT, Melin B, Deneen B, Bondy ML; Gliogene Consortium; Genomics England Research Consortium; Bainbridge MN, Amos CI, Barnholtz-Sloan JS, Bernstein JL, Claus EB, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lachance D, Lai R, Melin BS, Merrell RT, Olson SH, Sadetzki S, Schildkraut J, Shete S, Ambrose JC, Arumugam P, Bevers R, Bleda M, Boardman-Pretty F, Boustred CR, Brittain H, Brown MA, Caulfield MJ, Chan GC, Giess A, Griffin JN, Hamblin A, Henderson S, Hubbard TJP, Jackson R, Jones LJ, Kasperaviciute D, Kayikci M, Kousathanas A, Lahnstein L, Lakey A, Leigh SEA, Leong IUS, Lopez FJ, Maleady-Crowe F, McEntagart M, Minneci F, Mitchell J, Moutsianas L, Mueller M, Murugaesu N, Need AC, O'Donovan P, Odhams CA, Patch C, Perez-Gil D, Pereira MB, Pullinger J, Rahim T, Rendon A, Rogers T, Savage K, Sawant K, Scott RH, Siddiq A, Sieghart A, Smith SC, Sosinsky A, Stuckey A, Tanguy M, Taylor Tavares AL, Thomas ERA, Thompson SR, Tucci A, Welland MJ, Williams E, Witkowska K, Wood SM, Zarowiecki M.
The genomic landscape of familial glioma.
Sci Adv. 2023 Apr 28;9(17):eade2675. doi: 10.1126/sciadv.ade2675. PMID: 37115922. Laboratory investigation. ˍ

Choudhary D, Mohan V, Varsha AS, Hegde A, Menon G.
Neurosurgical emergencies during pregnancy - Management dilemmas.
Surg Neurol Int. 2023 Apr 28;14:151
. doi: 10.25259/SNI_1076_2022. PMID: 37151438. Observational study. ˍ

de Godoy LL, Mohan S, Wang S, Nasrallah MP, Sakai Y, O'Rourke DM, Bagley S, Desai A, Loevner LA, Poptani H, Chawla S.
Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas.
J Transl Med. 2023 Apr 28;21(1):287. doi: 10.1186/s12967-023-03941-x. PMID: 37118754. Observational study. ˍ

Kalita O, Kazda T, Reguli S, Jancalek R, Fadrus P, Slachta M, Pospisil P, Krska L, Vrbkova J, Hrabalek L, Smrcka M, Lipina R.
Effects of Reoperation Timing on Survival among Recurrent Glioblastoma Patients: A Retrospective Multicentric Descriptive Study.
Cancers (Basel). 2023 Apr 28;15(9):2530. doi: 10.3390/cancers15092530. PMID: 37173996. Observational study. ˍ

Smith NJ, Deaton TK, Territo W, Graner B, Gauger A, Snyder SE, Schulte ML, Green MA, Hutchins GD, Veronesi MC.
Hybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases.
J Nucl Med. 2023 Apr 28:jnumed.122.265149. doi: 10.2967/jnumed.122.265149. PMID: 37116915. Observational study. ˍ

Zittoun J, Dangouloff-Ros V, Cardoen L, Rutten C, Bolle S, Alapetite C, Levy R, Grévent D, Grill J, Brisse HJ, Doz F, Blauwblomme T, Beccaria K, Charpy S, Roux CJ, Varlet P, Dufour C, Puget S, Boddaert N.
How can we differentiate supratentorial tumor recurrence from postradiation imaging changes in children treated for primary malignant brain tumors?
J Neurosurg Pediatr. 2023 Apr 28:1-11. doi: 10.3171/2023.3.PEDS22386. PMID: 37119099. Observational study˰ ˍ

Antkowiak L, Zimny M, Starszak K, Sordyl R, Mandera M.
Surgical Treatment of Pediatric Incidentally Found Brain Tumors: A Single-Center Experience.
Brain Sci. 2023 Apr 29;13(5):746
. doi: 10.3390/brainsci13050746. PMID: 37239218. Observational study. ˍ